<DOC>
	<DOCNO>NCT01534520</DOCNO>
	<brief_summary>This study design evaluate self-inserted intravaginal 2 % lidocaine gel effective decreasing pain intrauterine device insertion nulliparous woman .</brief_summary>
	<brief_title>Self-administered Intravaginal 2 % Lidocaine Gel Prior Intrauterine Device Insertion Nulliparous Women</brief_title>
	<detailed_description>Intrauterine device ( IUDs ) among effective form reversible contraception . Numerous study demonstrate safety efficacy nulliparous woman , however , uptake IUDs group low . One major barrier woman obtain IUDs fear pain insertion , study demonstrate nulliparous woman experience pain parous woman IUD insertion . Studies evaluate various method pain control IUD insertion show conflict result , leave question unanswered best method decrease pain IUD insertion . This study aim evaluate novel approach pain control woman self-insert lidocaine gel vagina least 5 minute prior IUD insertion . This overcome barrier study may ample time lidocaine take effect , time eliminate need woman multiple speculum exam . Although novel approach administer anesthetic , believe woman interested intervention may potentially alleviate pain IUD insertion . If study demonstrate pain decrease self-inserted lidocaine compare placebo gel , potentially eliminate one large barrier nulliparous woman receive IUDs . Increased uptake highly effective contraception nulliparous woman one many step necessary towards decrease unintended pregnancy .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Inclusion criterion : Nulliparous , define study history pregnancy â‰¥ 24 week gestational age Desires insertion either levonorgestrelreleasing IUD ( LNGIUD ) copper T380A IUD ( CuIUD ) No history pregnancy last 6 week Able provide write informed consent English comply study procedure Exclusion criterion : Known allergy hypersensitivity lidocaine amino amide local anesthetic Prior fail IUD insertion Prior IUD use Use narcotic benzodiazepine medication within last 24 hour U.S. Centers Disease Control Medical Eligibility Criteria ( MEC ) category 3 4 classification use IUD Positive pregnancy test reasonable risk pregnancy due unprotected heterosexual intercourse since last menstrual period</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Intrauterine Device</keyword>
	<keyword>Pain</keyword>
	<keyword>Lidocaine</keyword>
</DOC>